Search
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.
Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.
One woman’s rare melanoma sparked research led by MSK physician-scientist Rich White involving zebrafish. The surprising results could lead to an entirely new treatment approach.
Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.
After more than two decades of providing outstanding cancer care to the people of New Jersey, Memorial Sloan Kettering announced today that its newest outpatient treatment center, in Bergen County, will welcome new patients in the coming weeks. In recognition of its debut, MSK’s leadership, joined by members of the community and local elected officials, gathered at the Montvale site to unveil MSK Bergen, a sleek, modern, technology-filled 110,000-plus-square-foot clinical program located on Summit Avenue, mere minutes from the Garden State Parkway.
Find out how you can help Memorial Sloan Kettering through the national blood shortage.
"Get the Vaccine to Save Lives" aims to help Americans feel safe and confident about receiving a COVID-19 vaccine.
Researchers are looking for ways to make cancer cells more visible to the immune system.
A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.